| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis
|
Vuppalanchi, Raj
|
|
|
5 |
10 |
p.
|
artikel
|
| 2 |
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
|
Hammoutene, Adel
|
|
|
5 |
10 |
p.
|
artikel
|
| 3 |
Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
|
Mulé, Sébastien
|
|
|
5 |
10 |
p.
|
artikel
|
| 4 |
Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
|
Li, Rui
|
|
|
5 |
10 |
p.
|
artikel
|
| 5 |
Contents
|
|
|
|
5 |
10 |
p.
|
artikel
|
| 6 |
Copyright and information
|
|
|
|
5 |
10 |
p.
|
artikel
|
| 7 |
Daytime napping, nighttime sleeping duration, and risk of hepatocellular carcinoma and liver disease-related mortality
|
Long, Lu
|
|
|
5 |
10 |
p.
|
artikel
|
| 8 |
Editorial Board page
|
|
|
|
5 |
10 |
p.
|
artikel
|
| 9 |
Erratum to: “Enhanced Liver Fibrosis® test predicts liver-related outcomes in the general population” (JHEP Reports 2023; 5: 100765)
|
Saarinen, Kustaa
|
|
|
5 |
10 |
p.
|
artikel
|
| 10 |
Erratum to ‘Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease’ (JHEP Reports 5 [2023] 100836)
|
Cheng, Yu-Ming
|
|
|
5 |
10 |
p.
|
artikel
|
| 11 |
Evaluation of the HBV liver reservoir with fine needle aspirates
|
Testoni, Barbara
|
|
|
5 |
10 |
p.
|
artikel
|
| 12 |
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
|
Martinello, Marianne
|
|
|
5 |
10 |
p.
|
artikel
|
| 13 |
HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
|
Roade, Luisa
|
|
|
5 |
10 |
p.
|
artikel
|
| 14 |
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
|
Atallah, Edmond
|
|
|
5 |
10 |
p.
|
artikel
|
| 15 |
Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse
|
Daniel, Jules
|
|
|
5 |
10 |
p.
|
artikel
|
| 16 |
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication
|
Kong, Xu
|
|
|
5 |
10 |
p.
|
artikel
|
| 17 |
Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2
|
Wang, Siying
|
|
|
5 |
10 |
p.
|
artikel
|
| 18 |
Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: Implications for hepatocellular carcinoma
|
Clerbaux, Laure-Alix
|
|
|
5 |
10 |
p.
|
artikel
|
| 19 |
Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe
|
Jordan, Veronica Clavijo
|
|
|
5 |
10 |
p.
|
artikel
|
| 20 |
Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
|
Eng, Pei Chia
|
|
|
5 |
10 |
p.
|
artikel
|
| 21 |
On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
|
Yang, Zeyuan
|
|
|
5 |
10 |
p.
|
artikel
|
| 22 |
Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy
|
Gonzales, Emmanuel
|
|
|
5 |
10 |
p.
|
artikel
|
| 23 |
Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis
|
Juneja, Pinky
|
|
|
5 |
10 |
p.
|
artikel
|
| 24 |
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
|
Lim, Young-Suk
|
|
|
5 |
10 |
p.
|
artikel
|
| 25 |
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
|
Martínez–Sánchez, Celia
|
|
|
5 |
10 |
p.
|
artikel
|
| 26 |
Tissue-resident and innate-like T cells in patients with advanced chronic liver disease
|
Ibidapo-Obe, Oluwatomi
|
|
|
5 |
10 |
p.
|
artikel
|
| 27 |
Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights
|
Ji, Gu-Wei
|
|
|
5 |
10 |
p.
|
artikel
|
| 28 |
Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury
|
Cao, Qi
|
|
|
5 |
10 |
p.
|
artikel
|
Tijdschrift beschrijving